The altered coupling leads to disruption of mGluR5-mediated production of 2-arachidonoyl-sn-glycerol (2-AG) in the ventral striatum and prefrontal cortex of FXS mouse models [43]. The gene discussed is GRM5; the disease is fragile X syndrome.